19.06.2013 - 20.06.2013, Copenhagen (DK)
9th Bio Production Forum
This conference will provide information about the changes in the Annex 2 and the
impact of these changes on biopharmaceutical development and manufacturing.
Expert speakers from authorities, industry and laboratories with experiences on different
types of biopharmaceuticals, e.g. vaccines, gene therapeutics ATMP, will
present their experiences on implementation of the Annex 2. They show you the
regulatory requirements as well as practical approaches to realize GMP standards in
biopharmaceutical development and manufacturing companies. It will be a unique
chance to discuss the different points of view with speakers and colleagues.
Kontakt: CONCEPT Heidelberg GmbH
Tel.: +49 (0) 6221/84 44-0